Vascular dementia
Vascular dementia (VD) is a type of clinical mental disorder caused by vascular disease, and is also a type of clinical outcome of cerebrovascular disease. Cerebrovascular dementia or vascular dementia (VD) refers to a comprehensive decline in intelligence caused by cerebral blood supply disorders due to cerebrovascular disease. That is, a brain function degeneration disease caused by cerebrovascular disease with dementia as the main clinical manifestation. It often starts at the age of 50 to 60, and about half of them are complicated by primary hypertension, with a step-by-step deterioration of intelligence. Cerebrovascular dementia is more common in patients with repeated "mini-strokes", and the condition gradually worsens with each "mini-stroke". Intellectual decline is not progressive, but develops in a step-by-step manner. After the recovery of the "mini-stroke", the intelligence has recovered to a certain extent and the condition is stable; however, after another "mini-stroke", the attack worsens again, developing intermittently, and finally dementia occurs.
-
Site of disease:
Blood vessels brain -
Infectious :
Not contagious -
Frequent population:
The elderly and smokers are more likely to suffer from -
Related symptoms:
Brain weakness syndrome emotional restlessness insomnia intelligence decline anxiety
Related Drugs
Nicergoline for injection
Indication: 1. Improve low desire and emotional disorders (slow reaction, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.) caused by cerebral arteriosclerosis and sequelae of cerebral stroke. 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation). It is also suitable for vascular dementia, especially in the early stage of treatment, it can improve cognition, memory, etc., and can reduce the severity of the disease.
Manufacturer:
Chengdu Tiantai Mountain Pharmaceutical Co., Ltd.
Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:
Hainan Lingkang Pharmaceutical Co., Ltd.
Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:
Hainan Poly Pharm. Co., Ltd.
Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:
Hainan Tongyong Kangli Pharmaceutical Co., Ltd.
Nicergoline for injection
Indication: 1. Improve the low will and emotional disorders caused by the sequelae of cerebral infarction (slow sensation, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.). 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Nicergoline Tablets
Indication: 1. Improve low desire and emotional disorders (slow reaction, lack of concentration, memory loss, lack of ideas, depression, anxiety, etc.) caused by cerebral arteriosclerosis and sequelae of cerebral stroke. 2. Acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, other symptoms of poor peripheral circulation). It is also suitable for vascular dementia, especially in the early stage of treatment, it can improve cognition, memory, etc., and can reduce the severity of the disease.
Manufacturer:
Viatris Pharmaceuticals (DALIAN) Co., Ltd.
Nicergoline Tablets
Indication: It is used for acute and chronic peripheral circulatory disorders (limb vascular occlusive disease, Raynaud's syndrome, and other symptoms of poor peripheral circulation). It is also suitable for vascular dementia, especially in the early stage of treatment, it can improve cognition, memory, etc. and reduce the severity of the disease.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Manufacturer:
Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
Cerebroprotein Hydrolysate Injection
Indication: -Primary dementia (such as Alzheimer's type senile dementia). -Vascular dementia (such as multi-infarct dementia, etc.) and cognitive dysfunction after mild or moderate stroke. -Mixed dementia. -Improvement of brain dysfunction after craniocerebral injury.
Related Ingredients